Clinical Trial

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The Sponsor is developing a progestin-only contraceptive transdermal system (patch). The main purpose of this study is to look at how safe the study patch is and how well it works in preventing pregnancy. The study will also look at how well the study patch is tolerated. The study patch is a transdermal system that contains the active ingredient, progestin.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-07
notable Primary completion pushed: 2027-03 -> 2027-05 2026-05-07
minor Completion pushed: 2027-04 -> 2027-05 2026-05-07
Trial Details
NCT Number NCT06672016
Lead Sponsor Mylan Pharmaceuticals Inc
Conditions Female Contraception
Enrollment 1,630 participants
Start Date 2025-01-13
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-05-06